Advertisement

Jansen Jab Gets The EMA’s Go Ahead

The benefits of the Johnson & Johnson Covid-19 vaccine outweigh the risks - that’s what the...

Share this article

09.41 21 Apr 2021


Jansen Jab Gets The EMA’s Go Ahead


Listen to this episode


Share this article

09.41 21 Apr 2021


The benefits of the Johnson & Johnson Covid-19 vaccine outweigh the risks - that’s what the European Medicines Agency concluded yesterday. Concerns about the Jansen jab’s safety had been raised following reports of a small number of blood clots in US recipients. Professor of Experimental Immunology at Trinity College Dublin, Kingston Mills joined us this morning.

Listen and subscribe to Newstalk Breakfast on Apple Podcasts or Spotify.

   

Download, listen and subscribe on the Newstalk App.

  

You can also listen to Newstalk live on newstalk.com or on Alexa, by adding the Newstalk skill and asking: 'Alexa, play Newstalk'.


Read more about

Breakfast Covid Vaccine Jansen Vaccine Johnson And Johnson Newstalk Newstalk Breakfast Vaccine

Related Episodes

Race for the Áras: Who’s is th...

00:23:12

Race for the Áras: Who’s is the early mix for Presidential Election 2025?

Newstalk Daily

00:23:12


The Story of Thin Lizzy

00:19:41

The Story of Thin Lizzy

The Hard Shoulder Highlights

00:19:41


James McCabe

00:07:03

James McCabe

The Hard Shoulder Highlights

00:07:03


Eamon Ryan

00:12:03

Eamon Ryan

The Hard Shoulder Highlights

00:12:03